AEON | AEON Biopharma, Inc. Annual & Quarterly Income

Annual Income Statements

(In USD)

Breakdown	2022	2021	2020	2019
Revenue	-	-	2.51 Million	3.35 Million
Cost of Revenue	-	-	-	1000.00
Gross Profit	-	-	2.51 Million	3.35 Million
Operating Expenses	48.42 Million	36.88 Million	18.9 Million	51.72 Million
Selling, General and Administrative Expenses	13.67 Million	11.15 Million	11.58 Million	46.03 Million
Research and Development Expenses	34.75 Million	25.72 Million	7.31 Million	4.81 Million
Other Expenses	-	10.21 Million	-5.61 Million	-10.75 Million
Cost and Expenses	48.42 Million	36.88 Million	18.9 Million	51.72 Million
Operating Income	-48.42 Million	-65.84 Million	-16.38 Million	-53.96 Million
Interest Expense	-	-	15 Thousand	7.47 Million
Income Tax Expense	-160.48 Thousand	28.96 Million	15 Thousand	-14.64 Million
Earnings before Tax	-52.55 Million	-55.63 Million	-32.91 Million	145.67 Million
Net Income	-52.55 Million	-55.63 Million	-32.91 Million	172.92 Million
Earnings Per Share Basic	-	-2.53	-2.22	11.69
Earnings Per Share Diluted	-	-2.53	-2.22	11.69
Weighted Average Shares Outstanding	-	21.99 Million	14.79 Million	14.79 Million
Weighted Average Shares Outstanding (Diluted)	-	21.99 Million	14.79 Million	14.79 Million
Gross Margin	-	-	1.00	1.00
EBIT Margin	-	-	-8.79	-15.02
Profit Margin	-	-	-13.07	51.51
EBITDA	-48.36 Million	-7.91 Million	-22.14 Million	-50.4 Million
Earnings Before Tax Margin	-	-	-6.51	-16.08

Breakdown	2024 Q2	2024 Q1	2023 Q2	2023 Q1	2022 FY	2022 Q4
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	7.76 Million	10.38 Million	13.97 Million	13.04 Million	48.42 Million	15.03 Million
Selling, General and Administrative Expenses	3.32 Million	4.64 Million	4.94 Million	3.84 Million	-	5.5 Million
Research and Development Expenses	4.43 Million	5.73 Million	9.02 Million	9.2 Million	-	9.52 Million
Other Expenses	1.82 Million	-48 Thousand	-1.4 Million	-4.59 Million	-4.12 Million	-19.53 Million
Cost and Expenses	7.76 Million	10.38 Million	13.97 Million	13.04 Million	48.42 Million	15.03 Million
Operating Income	153.47 Million	-74.15 Million	-13.97 Million	-13.04 Million	-48.42 Million	-15.03 Million
Interest Expense	-	-	-	-	-	-
Income Tax Expense	-170.04 Million	107.58 Million	-	-16.58 Thousand	-160.48 Thousand	-22.88 Thousand
Earnings before Tax	164.11 Million	-118.01 Million	-15.37 Million	-17.63 Million	-52.55 Million	-34.56 Million
Net Income	164.11 Million	-118.01 Million	-15.37 Million	-17.63 Million	-52.55 Million	-34.56 Million
Earnings Per Share Basic	4.22	-3.17	-0.56	-0.80	-	-
Earnings Per Share Diluted	4.22	-3.17	-0.56	-0.80	-	-
Weighted Average Shares Outstanding	38.84 Million	37.26 Million	27.43 Million	21.99 Million	-	-
Weighted Average Shares Outstanding (Diluted)	38.84 Million	37.26 Million	27.43 Million	21.99 Million	-	-
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-177.77 Million	97.23 Million	-13.94 Million	-13.02 Million	-	-15 Million
Earnings Before Tax Margin	-	-	-	-	-	-